Michael Andriole
Chief Executive Officer at CHIMERIX, INC.
Net worth: 473 842 $ as of 2024-03-30
Profile
Michael T.
Andriole is currently the President, Chief Executive Officer & Director at Chimerix, Inc. Prior to his current position, he served as the Vice President-Corporate Business Development at Eli Lilly & Co. from 2014 to 2017.
He also worked as the Chief Financial Officer at Endocyte, Inc. in 2017 and 2018.
Mr. Andriole holds an MBA from Kelley School of Business and an undergraduate degree from Williams College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CHIMERIX, INC.
0.50% | 2024-02-13 | 447,021 ( 0.50% ) | 473 842 $ | 2024-03-30 |
Michael Andriole active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIX, INC. | Chief Executive Officer | 2023-07-31 |
Former positions of Michael Andriole
| Companies | Position | End |
|---|---|---|
| ENDOCYTE, INC. | Director of Finance/CFO | 2018-11-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2017-01-31 |
Training of Michael Andriole
| Kelley School of Business | Masters Business Admin |
| Williams College of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Stock Market
- Insiders
- Michael Andriole
